GELS logo

Gelteq Limited Stock Price

NasdaqCM:GELS Community·US$9.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

GELS Share Price Performance

US$1.02
-1.29 (-55.84%)
US$1.02
-1.29 (-55.84%)
Price US$1.02

GELS Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slight risk with imperfect balance sheet.

4 Risks
0 Rewards

Gelteq Limited Key Details

AU$377.8k

Revenue

AU$175.1k

Cost of Revenue

AU$202.8k

Gross Profit

AU$5.4m

Other Expenses

-AU$5.2m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
-0.54
53.66%
-1,366.94%
20.7%
View Full Analysis

About GELS

Founded
2017
Employees
8
CEO
Nathan Givoni
WebsiteView website
www.gelteq.com

Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.

Recent GELS News & Updates

Recent updates

No updates